Chronic Obstructive Pulmonary Disease (COPD)
Conditions
Interventions
Cold Region COPD Patient Cohort:Routine Clinical Practice and Follow-up
Sponsors
The Second Affiliated Hospital of Harbin Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Age >=18 and =40 years for interventional subgroups); 2. Diagnosed with Chronic Obstructive Pulmonary Disease (COPD) according to GOLD 2019 guidelines; 3. Voluntarily participate and sign the informed consent form;
Exclusion criteria
Exclusion criteria: 1. Significant immunodeficiency; 2. Participation in other lung drug studies within 30 days prior to this study; 3. Lung diseases requiring intervention; 4. History of lobectomy, lung volume reduction surgery (LVRS), or lung transplantation; 5. Any disease or condition interfering with initial or subsequent assessment; 6. Other conditions deemed unsuitable by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Outcome: Baseline prevalence of sarcopenia in COPD patients in cold regions; | — |
Secondary
| Measure | Time frame |
|---|---|
| Frequency of acute exacerbations;all-cause mortality;readmission rate; | — |
Countries
China
Contacts
Public ContactHou Gang
The Second Affiliated Hospital of Harbin Medical University
Outcome results
None listed